These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32774806)

  • 21. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central 5-HT1A receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice.
    Youn J; Hager T; Misane I; Pieneman AW; Jansen RF; Ogren SO; Meyer M; Stiedl O
    Br J Pharmacol; 2013 Oct; 170(4):859-70. PubMed ID: 23902597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of 5-HT(1A) receptors attenuates tachycardia induced by restraint stress in rats.
    Ngampramuan S; Baumert M; Beig MI; Kotchabhakdi N; Nalivaiko E
    Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R132-41. PubMed ID: 17959705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centrally coinjected galanin and a 5-HT1A agonist act synergistically to produce vasodepressor responses in the rat.
    Hedlund PB; Aguirre JA; Narvaez JA; Fuxe K
    Eur J Pharmacol; 1991 Oct; 204(1):87-95. PubMed ID: 1725157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Hibert M; van den Buuse M
    Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B; Kotai E; Weisz E; Singer EA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological study of cholinergic system on cardiovascular regulation in the cuneiform nucleus of rat.
    Shafei MN; Niazmand S; Enayatfard L; Hosseini M; Daloee MH
    Neurosci Lett; 2013 Aug; 549():12-7. PubMed ID: 23811029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage.
    Osei-Owusu P; Scrogin KE
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1132-40. PubMed ID: 14769835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.
    Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL
    Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.
    Zhou X; Zhang R; Zhang S; Wu J; Sun X
    J Neurosci; 2019 Feb; 39(8):1484-1504. PubMed ID: 30541912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic 8-OH-DPAT challenge causes hyperventilation largely via activating pre-botzinger complex 5-HT
    Zhuang J; Xu F
    Respir Physiol Neurobiol; 2022 Feb; 296():103810. PubMed ID: 34728431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of low doses of the 5-HT
    Sandoval-Sánchez AR; Cedillo Zavaleta LN; Jiménez JC; Ruíz-García I; Miranda F
    Pharmacol Biochem Behav; 2020 Jun; 193():172932. PubMed ID: 32315693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
    Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
    Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.